

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 9.86170243 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.36980716 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.88847806 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.11390627 |
| 5 | regulation of guanylate cyclase activity (GO:0031282) | 6.92972038 |
| 6 | NADH metabolic process (GO:0006734) | 6.90327792 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64174624 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 6.64174624 |
| 9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.58470847 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.39567264 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 6.39567264 |
| 12 | hormone catabolic process (GO:0042447) | 6.02518166 |
| 13 | fructose metabolic process (GO:0006000) | 5.90267513 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.89589785 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.88309195 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.79111536 |
| 17 | lipoprotein transport (GO:0042953) | 5.76946969 |
| 18 | intestinal cholesterol absorption (GO:0030299) | 5.76383223 |
| 19 | urea metabolic process (GO:0019627) | 5.55765285 |
| 20 | urea cycle (GO:0000050) | 5.55765285 |
| 21 | regulation of triglyceride catabolic process (GO:0010896) | 5.51616600 |
| 22 | phospholipid efflux (GO:0033700) | 5.47567561 |
| 23 | reverse cholesterol transport (GO:0043691) | 5.34632875 |
| 24 | indole-containing compound catabolic process (GO:0042436) | 5.22641158 |
| 25 | indolalkylamine catabolic process (GO:0046218) | 5.22641158 |
| 26 | tryptophan catabolic process (GO:0006569) | 5.22641158 |
| 27 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.18658672 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 5.15590588 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 5.15590588 |
| 30 | macromolecular complex remodeling (GO:0034367) | 5.15590588 |
| 31 | kynurenine metabolic process (GO:0070189) | 5.14834392 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 5.09942582 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.09626973 |
| 34 | cysteine metabolic process (GO:0006534) | 5.09582692 |
| 35 | glyoxylate metabolic process (GO:0046487) | 5.08098858 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 5.06100163 |
| 37 | negative regulation of sterol transport (GO:0032372) | 5.06100163 |
| 38 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.04243273 |
| 39 | endocrine process (GO:0050886) | 5.04243273 |
| 40 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.04243273 |
| 41 | bile acid biosynthetic process (GO:0006699) | 4.98965042 |
| 42 | intestinal absorption (GO:0050892) | 4.98828361 |
| 43 | negative regulation of leukocyte chemotaxis (GO:0002689) | 4.98196699 |
| 44 | tryptophan metabolic process (GO:0006568) | 4.91091283 |
| 45 | cholesterol efflux (GO:0033344) | 4.88576728 |
| 46 | sulfur amino acid catabolic process (GO:0000098) | 4.87110737 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 4.87000792 |
| 48 | bile acid and bile salt transport (GO:0015721) | 4.85452724 |
| 49 | diacylglycerol metabolic process (GO:0046339) | 4.85126644 |
| 50 | plasma lipoprotein particle assembly (GO:0034377) | 4.84676886 |
| 51 | drug catabolic process (GO:0042737) | 4.82585472 |
| 52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.72070922 |
| 53 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.72070922 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.69023188 |
| 55 | acylglycerol homeostasis (GO:0055090) | 4.69023188 |
| 56 | regulation of fibrinolysis (GO:0051917) | 4.64908819 |
| 57 | bile acid metabolic process (GO:0008206) | 4.62482774 |
| 58 | homocysteine metabolic process (GO:0050667) | 4.62220768 |
| 59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.59821649 |
| 60 | protein carboxylation (GO:0018214) | 4.59821649 |
| 61 | regulation of systemic arterial blood pressure (GO:0003073) | 4.51790464 |
| 62 | flavonoid metabolic process (GO:0009812) | 4.49538868 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 4.48839682 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.44073297 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.43001823 |
| 66 | protein-lipid complex assembly (GO:0065005) | 4.41283674 |
| 67 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.35775276 |
| 68 | regulation of protein activation cascade (GO:2000257) | 4.33437717 |
| 69 | regulation of cGMP biosynthetic process (GO:0030826) | 4.30038360 |
| 70 | alkaloid metabolic process (GO:0009820) | 4.29999255 |
| 71 | aromatic amino acid family metabolic process (GO:0009072) | 4.27675756 |
| 72 | regulation of bile acid biosynthetic process (GO:0070857) | 4.27232997 |
| 73 | complement activation, alternative pathway (GO:0006957) | 4.26195254 |
| 74 | renal system process involved in regulation of blood volume (GO:0001977) | 4.26130710 |
| 75 | amino-acid betaine metabolic process (GO:0006577) | 4.24457780 |
| 76 | cellular glucuronidation (GO:0052695) | 4.24141124 |
| 77 | cholesterol homeostasis (GO:0042632) | 4.23795191 |
| 78 | adhesion of symbiont to host cell (GO:0044650) | 4.21917432 |
| 79 | virion attachment to host cell (GO:0019062) | 4.21917432 |
| 80 | lysine catabolic process (GO:0006554) | 4.19540602 |
| 81 | lysine metabolic process (GO:0006553) | 4.19540602 |
| 82 | sterol homeostasis (GO:0055092) | 4.17420555 |
| 83 | lipoprotein metabolic process (GO:0042157) | 4.16433118 |
| 84 | tyrosine metabolic process (GO:0006570) | 4.14793794 |
| 85 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.13012899 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 4.11790866 |
| 87 | plasma lipoprotein particle organization (GO:0071827) | 4.07798186 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 4.04697377 |
| 89 | vitamin transmembrane transport (GO:0035461) | 4.04501507 |
| 90 | peptide catabolic process (GO:0043171) | 4.03063946 |
| 91 | omega-hydroxylase P450 pathway (GO:0097267) | 4.02847162 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 4.01376210 |
| 93 | regulation of complement activation (GO:0030449) | 3.99005986 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95516638 |
| 95 | glutamate metabolic process (GO:0006536) | 3.92773369 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.91496027 |
| 97 | regulation of cellular extravasation (GO:0002691) | 3.89918677 |
| 98 | arginine metabolic process (GO:0006525) | 3.89910262 |
| 99 | peptide hormone processing (GO:0016486) | 3.89160713 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 3.87562043 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.87234187 |
| 102 | vitamin transport (GO:0051180) | 3.79763692 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.77629365 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.77629365 |
| 105 | drug metabolic process (GO:0017144) | 3.75961737 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.75812876 |
| 107 | benzene-containing compound metabolic process (GO:0042537) | 3.73073350 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 3.72046596 |
| 109 | indolalkylamine metabolic process (GO:0006586) | 3.68660779 |
| 110 | glycine metabolic process (GO:0006544) | 3.68600443 |
| 111 | midgut development (GO:0007494) | 3.67803135 |
| 112 | imidazole-containing compound metabolic process (GO:0052803) | 3.66978075 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 3.66632539 |
| 114 | coenzyme catabolic process (GO:0009109) | 3.65789237 |
| 115 | negative regulation of lipase activity (GO:0060192) | 3.65146727 |
| 116 | adhesion of symbiont to host (GO:0044406) | 3.64487272 |
| 117 | regulation of cGMP metabolic process (GO:0030823) | 3.63565369 |
| 118 | serine family amino acid biosynthetic process (GO:0009070) | 3.63237832 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.61448214 |
| 120 | digestion (GO:0007586) | 3.58946638 |
| 121 | cellular biogenic amine catabolic process (GO:0042402) | 3.58560755 |
| 122 | amine catabolic process (GO:0009310) | 3.58560755 |
| 123 | exogenous drug catabolic process (GO:0042738) | 3.57641401 |
| 124 | ketone body metabolic process (GO:1902224) | 3.55460529 |
| 125 | sterol transport (GO:0015918) | 3.54884146 |
| 126 | cholesterol transport (GO:0030301) | 3.54884146 |
| 127 | regulation of macrophage chemotaxis (GO:0010758) | 3.54151313 |
| 128 | heme transport (GO:0015886) | 3.53382559 |
| 129 | antibacterial humoral response (GO:0019731) | 3.53122838 |
| 130 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.52491980 |
| 131 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51701820 |
| 132 | ethanol oxidation (GO:0006069) | 3.51574905 |
| 133 | vitamin biosynthetic process (GO:0009110) | 3.48724535 |
| 134 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.48648149 |
| 135 | fat-soluble vitamin metabolic process (GO:0006775) | 3.48180850 |
| 136 | drug transmembrane transport (GO:0006855) | 3.47595152 |
| 137 | response to nitrosative stress (GO:0051409) | 3.46609787 |
| 138 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.43912253 |
| 139 | urate metabolic process (GO:0046415) | 3.43741304 |
| 140 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.42626094 |
| 141 | antimicrobial humoral response (GO:0019730) | 3.42223086 |
| 142 | vitamin A metabolic process (GO:0006776) | 3.40574705 |
| 143 | positive regulation of pseudopodium assembly (GO:0031274) | 3.39552469 |
| 144 | glycerol metabolic process (GO:0006071) | 3.34735110 |
| 145 | L-ascorbic acid metabolic process (GO:0019852) | 3.29786056 |
| 146 | drinking behavior (GO:0042756) | 3.29413848 |
| 147 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.28504402 |
| 148 | drug transport (GO:0015893) | 3.21790941 |
| 149 | cellular response to nitric oxide (GO:0071732) | 3.18363632 |
| 150 | ethanol metabolic process (GO:0006067) | 3.18039192 |
| 151 | glycolipid catabolic process (GO:0019377) | 3.15380084 |
| 152 | regulation of vitamin metabolic process (GO:0030656) | 3.09477468 |
| 153 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.08906099 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 3.07940317 |
| 155 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.07581170 |
| 156 | proline metabolic process (GO:0006560) | 3.07074554 |
| 157 | alditol metabolic process (GO:0019400) | 3.06818930 |
| 158 | phenylpropanoid metabolic process (GO:0009698) | 3.06209275 |
| 159 | regulation of pseudopodium assembly (GO:0031272) | 3.01489001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.85302578 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.87368529 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.33188684 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.20801620 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72199921 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71670612 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.66328795 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78822594 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.46756804 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.49575396 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.28442784 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.0030269 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90119161 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.70885504 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68606381 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66143891 |
| 17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65875762 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.65846587 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60757885 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54550386 |
| 21 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53221346 |
| 22 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44880381 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39072981 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37401772 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37341280 |
| 26 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36700530 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30393772 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26653034 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25508867 |
| 30 | SA1_27219007_Chip-Seq_Bcells_Human | 1.21009816 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.20006132 |
| 32 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17250155 |
| 33 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.13740280 |
| 34 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11551758 |
| 35 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.07747028 |
| 36 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03931332 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02336551 |
| 38 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.01911241 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00101308 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98653006 |
| 41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.98646842 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98495500 |
| 43 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.97554520 |
| 44 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97470849 |
| 45 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97159654 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95632950 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95363044 |
| 48 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92591006 |
| 49 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92481786 |
| 50 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92006137 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91520800 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91340719 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90471887 |
| 54 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90459000 |
| 55 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89990739 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89269069 |
| 57 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88164572 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86720465 |
| 59 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85373733 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85300664 |
| 61 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83152472 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82914723 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82584065 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.82377450 |
| 65 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82131393 |
| 66 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81572663 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80891476 |
| 68 | RXR_22108803_ChIP-Seq_LS180_Human | 0.80801487 |
| 69 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79930256 |
| 70 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79441058 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79409597 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.78275912 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77585693 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76714859 |
| 75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.76606829 |
| 76 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.74895140 |
| 77 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74620489 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74457213 |
| 79 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.74408620 |
| 80 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.74274096 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74113294 |
| 82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73558865 |
| 83 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73235390 |
| 84 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.72622669 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.72067307 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.71787596 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71640955 |
| 88 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.71591051 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.70641651 |
| 90 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70588584 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70473168 |
| 92 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.70428732 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70037211 |
| 94 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.69710271 |
| 95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69619774 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69374393 |
| 97 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66722629 |
| 98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.65419754 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63319315 |
| 100 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62673657 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.61887199 |
| 102 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.61017897 |
| 103 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60669999 |
| 104 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.60513886 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60404756 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60177739 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59702517 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.58851660 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.58196671 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57907556 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57549173 |
| 112 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.57497156 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.55952623 |
| 114 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55946197 |
| 115 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55330034 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55309251 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55309251 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.54044243 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.53913107 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.53825455 |
| 121 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.53730826 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53723737 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52717112 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52626016 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51874108 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.50845346 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.50773892 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.50136449 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49082243 |
| 130 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49039228 |
| 131 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.48450969 |
| 132 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48040373 |
| 133 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48006223 |
| 134 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47982371 |
| 135 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.47797362 |
| 136 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.46938362 |
| 137 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.44543678 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.44497065 |
| 139 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.43820893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.91260858 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.81377212 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.97344975 |
| 4 | MP0005365_abnormal_bile_salt | 5.48596837 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02725154 |
| 6 | MP0009840_abnormal_foam_cell | 3.98970951 |
| 7 | MP0003252_abnormal_bile_duct | 3.95059651 |
| 8 | MP0009379_abnormal_foot_pigmentation | 3.83318978 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.73603681 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.73586116 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.67489189 |
| 12 | MP0005332_abnormal_amino_acid | 2.63218944 |
| 13 | MP0005083_abnormal_biliary_tract | 2.44479418 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.37701994 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.35443879 |
| 16 | MP0003195_calcinosis | 2.22813019 |
| 17 | MP0000609_abnormal_liver_physiology | 2.00673115 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.00550436 |
| 19 | MP0005409_darkened_coat_color | 1.81863348 |
| 20 | MP0009697_abnormal_copulation | 1.69837468 |
| 21 | MP0005319_abnormal_enzyme/_coenzyme | 1.66027771 |
| 22 | MP0003868_abnormal_feces_composition | 1.64502891 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.61761205 |
| 24 | MP0001664_abnormal_digestion | 1.53927488 |
| 25 | MP0003879_abnormal_hair_cell | 1.52814050 |
| 26 | MP0001764_abnormal_homeostasis | 1.51193648 |
| 27 | MP0005451_abnormal_body_composition | 1.49579912 |
| 28 | MP0001188_hyperpigmentation | 1.48264149 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43921107 |
| 30 | MP0004858_abnormal_nervous_system | 1.41909926 |
| 31 | MP0010234_abnormal_vibrissa_follicle | 1.37990379 |
| 32 | MP0000566_synostosis | 1.36199049 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.35594998 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.35371261 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.34824220 |
| 36 | MP0000490_abnormal_crypts_of | 1.26456234 |
| 37 | MP0000604_amyloidosis | 1.14516961 |
| 38 | MP0002254_reproductive_system_inflammat | 1.13996511 |
| 39 | MP0005084_abnormal_gallbladder_morpholo | 1.13506942 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.11831779 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.11615436 |
| 42 | MP0004270_analgesia | 1.09944282 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.07051875 |
| 44 | MP0002098_abnormal_vibrissa_morphology | 1.04858964 |
| 45 | MP0000598_abnormal_liver_morphology | 1.03510289 |
| 46 | MP0002822_catalepsy | 1.00948269 |
| 47 | MP0003011_delayed_dark_adaptation | 0.98016670 |
| 48 | MP0001485_abnormal_pinna_reflex | 0.97164307 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.95313144 |
| 50 | MP0005636_abnormal_mineral_homeostasis | 0.94253462 |
| 51 | MP0009764_decreased_sensitivity_to | 0.89879427 |
| 52 | MP0003186_abnormal_redox_activity | 0.87051057 |
| 53 | MP0009642_abnormal_blood_homeostasis | 0.86766088 |
| 54 | MP0010352_gastrointestinal_tract_polyps | 0.86462301 |
| 55 | MP0005448_abnormal_energy_balance | 0.84564039 |
| 56 | MP0009763_increased_sensitivity_to | 0.80578045 |
| 57 | MP0008469_abnormal_protein_level | 0.78168257 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.77646663 |
| 59 | MP0001501_abnormal_sleep_pattern | 0.76330228 |
| 60 | MP0004742_abnormal_vestibular_system | 0.76221664 |
| 61 | MP0009765_abnormal_xenobiotic_induced | 0.74369734 |
| 62 | MP0009053_abnormal_anal_canal | 0.74132146 |
| 63 | MP0002078_abnormal_glucose_homeostasis | 0.72482822 |
| 64 | MP0005266_abnormal_metabolism | 0.70902472 |
| 65 | MP0005408_hypopigmentation | 0.70062955 |
| 66 | MP0005647_abnormal_sex_gland | 0.69820905 |
| 67 | MP0003183_abnormal_peptide_metabolism | 0.69652440 |
| 68 | MP0002971_abnormal_brown_adipose | 0.68454877 |
| 69 | MP0000462_abnormal_digestive_system | 0.65941153 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 0.65100576 |
| 71 | MP0004043_abnormal_pH_regulation | 0.64578977 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.63583565 |
| 73 | MP0003718_maternal_effect | 0.63553150 |
| 74 | MP0005334_abnormal_fat_pad | 0.62824749 |
| 75 | MP0003329_amyloid_beta_deposits | 0.62309639 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.60594801 |
| 77 | MP0001873_stomach_inflammation | 0.58979759 |
| 78 | MP0001756_abnormal_urination | 0.57861591 |
| 79 | MP0010368_abnormal_lymphatic_system | 0.57678691 |
| 80 | MP0000427_abnormal_hair_cycle | 0.56931369 |
| 81 | MP0008872_abnormal_physiological_respon | 0.56768383 |
| 82 | MP0002136_abnormal_kidney_physiology | 0.56199476 |
| 83 | MP0000383_abnormal_hair_follicle | 0.55976573 |
| 84 | MP0002796_impaired_skin_barrier | 0.55697077 |
| 85 | MP0004147_increased_porphyrin_level | 0.55062728 |
| 86 | MP0006138_congestive_heart_failure | 0.52220521 |
| 87 | MP0005535_abnormal_body_temperature | 0.51983590 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.51388644 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.50716192 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.50345850 |
| 91 | MP0002896_abnormal_bone_mineralization | 0.49845108 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.47682107 |
| 93 | MP0000516_abnormal_urinary_system | 0.47461214 |
| 94 | MP0005367_renal/urinary_system_phenotyp | 0.47461214 |
| 95 | MP0003690_abnormal_glial_cell | 0.47446345 |
| 96 | MP0001663_abnormal_digestive_system | 0.46540307 |
| 97 | MP0008873_increased_physiological_sensi | 0.46143430 |
| 98 | MP0001727_abnormal_embryo_implantation | 0.46041447 |
| 99 | MP0005501_abnormal_skin_physiology | 0.45986824 |
| 100 | MP0000639_abnormal_adrenal_gland | 0.45760907 |
| 101 | MP0005166_decreased_susceptibility_to | 0.45750409 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.44391391 |
| 103 | MP0003878_abnormal_ear_physiology | 0.44362129 |
| 104 | MP0005377_hearing/vestibular/ear_phenot | 0.44362129 |
| 105 | MP0005395_other_phenotype | 0.44237168 |
| 106 | MP0005670_abnormal_white_adipose | 0.44230480 |
| 107 | MP0005381_digestive/alimentary_phenotyp | 0.43796318 |
| 108 | MP0009785_altered_susceptibility_to | 0.43031349 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.42888947 |
| 110 | MP0003315_abnormal_perineum_morphology | 0.42568990 |
| 111 | MP0003953_abnormal_hormone_level | 0.41999093 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.41330307 |
| 113 | MP0006035_abnormal_mitochondrial_morpho | 0.38706118 |
| 114 | MP0009115_abnormal_fat_cell | 0.37624354 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.36800075 |
| 116 | MP0003075_altered_response_to | 0.36379444 |
| 117 | MP0000249_abnormal_blood_vessel | 0.35783569 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.35686441 |
| 119 | MP0005248_abnormal_Harderian_gland | 0.35660517 |
| 120 | MP0001661_extended_life_span | 0.35208762 |
| 121 | MP0008874_decreased_physiological_sensi | 0.34953068 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.32783148 |
| 123 | MP0003866_abnormal_defecation | 0.32670925 |
| 124 | MP0003436_decreased_susceptibility_to | 0.32588126 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.32017420 |
| 126 | MP0004130_abnormal_muscle_cell | 0.31982222 |
| 127 | MP0003453_abnormal_keratinocyte_physiol | 0.31263285 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.30730389 |
| 129 | MP0001881_abnormal_mammary_gland | 0.30632615 |
| 130 | MP0001845_abnormal_inflammatory_respons | 0.29872800 |
| 131 | MP0009384_cardiac_valve_regurgitation | 0.29826699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 7.25189274 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.71465323 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.60813608 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.53166611 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.45629909 |
| 6 | Xanthomatosis (HP:0000991) | 6.13607939 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.71369646 |
| 8 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.43969751 |
| 9 | Hypolipoproteinemia (HP:0010981) | 5.18007881 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.97622882 |
| 11 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.64676029 |
| 12 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.59791006 |
| 13 | Hyperammonemia (HP:0001987) | 4.47884526 |
| 14 | Widely patent fontanelles and sutures (HP:0004492) | 4.44824726 |
| 15 | Fat malabsorption (HP:0002630) | 4.39817138 |
| 16 | Chronic diarrhea (HP:0002028) | 4.34430604 |
| 17 | Abnormality of vitamin B metabolism (HP:0004340) | 4.32771036 |
| 18 | Hyperglycinuria (HP:0003108) | 4.31293025 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30913447 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 4.28643819 |
| 21 | Epidermoid cyst (HP:0200040) | 4.27832100 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.27197356 |
| 23 | Complement deficiency (HP:0004431) | 4.11333972 |
| 24 | Joint hemorrhage (HP:0005261) | 4.07522397 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.05431191 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 4.01876575 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99596950 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.99596950 |
| 29 | Ketosis (HP:0001946) | 3.91047503 |
| 30 | Hyperglycinemia (HP:0002154) | 3.82475783 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.79871128 |
| 32 | Acanthocytosis (HP:0001927) | 3.74388217 |
| 33 | Hypoglycemic coma (HP:0001325) | 3.70795391 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.66292631 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55413272 |
| 36 | Potter facies (HP:0002009) | 3.47205262 |
| 37 | Facial shape deformation (HP:0011334) | 3.47205262 |
| 38 | Hyperphosphaturia (HP:0003109) | 3.38043483 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.35762626 |
| 40 | Malnutrition (HP:0004395) | 3.34629829 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33114982 |
| 42 | Wide cranial sutures (HP:0010537) | 3.30187131 |
| 43 | Increased purine levels (HP:0004368) | 3.28591058 |
| 44 | Hyperuricemia (HP:0002149) | 3.28591058 |
| 45 | Abnormal urine phosphate concentration (HP:0012599) | 3.28318707 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22988084 |
| 47 | Thin bony cortex (HP:0002753) | 3.21649158 |
| 48 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18767464 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 3.17827180 |
| 50 | Hyperparathyroidism (HP:0000843) | 3.16102754 |
| 51 | Ketoacidosis (HP:0001993) | 3.00816528 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.99034135 |
| 53 | Abnormality of complement system (HP:0005339) | 2.98218281 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.98188685 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.98188685 |
| 56 | Metabolic acidosis (HP:0001942) | 2.97655348 |
| 57 | Congenital sensorineural hearing impairment (HP:0008527) | 2.96104093 |
| 58 | Ileus (HP:0002595) | 2.87944654 |
| 59 | Megaloblastic anemia (HP:0001889) | 2.86727840 |
| 60 | Spontaneous abortion (HP:0005268) | 2.82902098 |
| 61 | Hypophosphatemia (HP:0002148) | 2.80838229 |
| 62 | Steatorrhea (HP:0002570) | 2.78538316 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.74194010 |
| 64 | Abdominal distention (HP:0003270) | 2.71976826 |
| 65 | Hepatocellular carcinoma (HP:0001402) | 2.68881936 |
| 66 | Poikilocytosis (HP:0004447) | 2.68064085 |
| 67 | Skin nodule (HP:0200036) | 2.64004236 |
| 68 | Decreased circulating renin level (HP:0003351) | 2.61011934 |
| 69 | Abnormal gallbladder physiology (HP:0012438) | 2.60604645 |
| 70 | Cholecystitis (HP:0001082) | 2.60604645 |
| 71 | Vascular calcification (HP:0004934) | 2.58093227 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.57139723 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.57139723 |
| 74 | Abnormality of serum amino acid levels (HP:0003112) | 2.55251365 |
| 75 | Myocardial infarction (HP:0001658) | 2.51437412 |
| 76 | Lethargy (HP:0001254) | 2.49545005 |
| 77 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48696279 |
| 78 | Dicarboxylic aciduria (HP:0003215) | 2.48696279 |
| 79 | Nephritis (HP:0000123) | 2.45239217 |
| 80 | Amyloidosis (HP:0011034) | 2.44201103 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.43648506 |
| 82 | Cholelithiasis (HP:0001081) | 2.39672779 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.37700975 |
| 84 | Hypoglycemic seizures (HP:0002173) | 2.36367452 |
| 85 | Cerebral palsy (HP:0100021) | 2.35188712 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 2.34237157 |
| 87 | Gout (HP:0001997) | 2.34091045 |
| 88 | Late onset (HP:0003584) | 2.32465163 |
| 89 | Irritability (HP:0000737) | 2.30978903 |
| 90 | Glycosuria (HP:0003076) | 2.29743019 |
| 91 | Abnormality of urine glucose concentration (HP:0011016) | 2.29743019 |
| 92 | Metabolic alkalosis (HP:0200114) | 2.28752498 |
| 93 | Focal segmental glomerulosclerosis (HP:0000097) | 2.28734546 |
| 94 | Esophageal varix (HP:0002040) | 2.28238140 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.27402319 |
| 96 | Delayed epiphyseal ossification (HP:0002663) | 2.25196688 |
| 97 | Pancreatitis (HP:0001733) | 2.23749035 |
| 98 | Renal tubular dysfunction (HP:0000124) | 2.22803626 |
| 99 | Glomerulonephritis (HP:0000099) | 2.21326061 |
| 100 | Protuberant abdomen (HP:0001538) | 2.19230219 |
| 101 | Spastic diplegia (HP:0001264) | 2.19224515 |
| 102 | Posterior subcapsular cataract (HP:0007787) | 2.14797818 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.13508341 |
| 104 | Cerebral edema (HP:0002181) | 2.12055911 |
| 105 | Reticulocytosis (HP:0001923) | 2.10973834 |
| 106 | Vomiting (HP:0002013) | 2.08911030 |
| 107 | Generalized aminoaciduria (HP:0002909) | 2.06310693 |
| 108 | Hypotension (HP:0002615) | 2.06009988 |
| 109 | Abnormal glucose tolerance (HP:0001952) | 2.05232141 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 2.04910501 |
| 111 | Amblyopia (HP:0000646) | 2.04353503 |
| 112 | Renal tubular acidosis (HP:0001947) | 2.03608971 |
| 113 | Pigmentary retinal degeneration (HP:0001146) | 2.03080198 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.98913286 |
| 115 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.98433308 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98015147 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 1.97865056 |
| 118 | Enlarged epiphyses (HP:0010580) | 1.97794768 |
| 119 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96750599 |
| 120 | Mitral stenosis (HP:0001718) | 1.95419585 |
| 121 | Menorrhagia (HP:0000132) | 1.95102787 |
| 122 | Nephrolithiasis (HP:0000787) | 1.93687633 |
| 123 | Neonatal onset (HP:0003623) | 1.93246903 |
| 124 | Gingival bleeding (HP:0000225) | 1.93077506 |
| 125 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92238670 |
| 126 | Rickets (HP:0002748) | 1.91925979 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.91525169 |
| 128 | Brushfield spots (HP:0001088) | 1.89685158 |
| 129 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88514776 |
| 130 | Confusion (HP:0001289) | 1.88257890 |
| 131 | Enlarged kidneys (HP:0000105) | 1.88215087 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.86355794 |
| 133 | Nausea (HP:0002018) | 1.85739575 |
| 134 | Hyperactive renin-angiotensin system (HP:0000841) | 1.85530140 |
| 135 | Hemorrhage of the eye (HP:0011885) | 1.85018765 |
| 136 | Alkalosis (HP:0001948) | 1.84144154 |
| 137 | Abnormality of the costochondral junction (HP:0000919) | 1.82760373 |
| 138 | Autoimmune thrombocytopenia (HP:0001973) | 1.81772933 |
| 139 | Elevated alkaline phosphatase (HP:0003155) | 1.74502561 |
| 140 | Villous atrophy (HP:0011473) | 1.71796292 |
| 141 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.71796292 |
| 142 | Glomerulosclerosis (HP:0000096) | 1.71364237 |
| 143 | Hyperphosphatemia (HP:0002905) | 1.70942096 |
| 144 | Growth hormone excess (HP:0000845) | 1.70613653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRSK2 | 6.76839581 |
| 2 | ACVR1B | 6.29736928 |
| 3 | BCKDK | 5.52955243 |
| 4 | ERN1 | 4.35512365 |
| 5 | FRK | 4.26186489 |
| 6 | WEE1 | 3.91106431 |
| 7 | FGFR4 | 3.59090212 |
| 8 | SIK1 | 3.56427157 |
| 9 | MST1R | 3.54665730 |
| 10 | BRSK1 | 2.88750205 |
| 11 | GRK6 | 2.57147912 |
| 12 | TAOK3 | 2.56441197 |
| 13 | INSRR | 2.30944100 |
| 14 | SMG1 | 2.20819593 |
| 15 | RIPK1 | 2.18923187 |
| 16 | PTK6 | 2.11296841 |
| 17 | ERBB4 | 2.01351306 |
| 18 | PKN2 | 1.87772674 |
| 19 | CASK | 1.81990370 |
| 20 | MAP2K4 | 1.75459768 |
| 21 | AKT3 | 1.61680561 |
| 22 | MAP3K10 | 1.60771117 |
| 23 | MAPK11 | 1.60019009 |
| 24 | MAP2K2 | 1.59046702 |
| 25 | LMTK2 | 1.54155005 |
| 26 | TYK2 | 1.47889164 |
| 27 | TNIK | 1.46591294 |
| 28 | LATS1 | 1.45426382 |
| 29 | PRKG2 | 1.42881983 |
| 30 | PDK2 | 1.36874241 |
| 31 | MET | 1.34719419 |
| 32 | FLT3 | 1.34425919 |
| 33 | MAP3K11 | 1.34268056 |
| 34 | TRIB3 | 1.33478866 |
| 35 | MAP3K7 | 1.33113196 |
| 36 | DDR2 | 1.29776097 |
| 37 | MAP3K12 | 1.28443047 |
| 38 | PRKAA2 | 1.25223100 |
| 39 | MAP3K3 | 1.24534788 |
| 40 | DAPK2 | 1.22900087 |
| 41 | PIK3CG | 1.21008520 |
| 42 | KDR | 1.13121729 |
| 43 | PTK2 | 1.08107626 |
| 44 | MAP3K2 | 1.06095562 |
| 45 | MAP2K6 | 1.04226748 |
| 46 | ERBB2 | 1.01545413 |
| 47 | TBK1 | 1.01212375 |
| 48 | EPHB1 | 0.98534342 |
| 49 | ABL2 | 0.97419694 |
| 50 | STK39 | 0.97144828 |
| 51 | PIK3CA | 0.95413915 |
| 52 | PBK | 0.94993815 |
| 53 | MST4 | 0.92023342 |
| 54 | EPHA2 | 0.91879572 |
| 55 | TAF1 | 0.91062772 |
| 56 | JAK2 | 0.88014188 |
| 57 | NME1 | 0.87631972 |
| 58 | OXSR1 | 0.87285152 |
| 59 | NUAK1 | 0.85834190 |
| 60 | MATK | 0.84300403 |
| 61 | TESK1 | 0.84287184 |
| 62 | MAP2K3 | 0.83206558 |
| 63 | VRK2 | 0.81959464 |
| 64 | PRKCZ | 0.80922556 |
| 65 | MAPK4 | 0.78686080 |
| 66 | IRAK3 | 0.78651343 |
| 67 | EPHB2 | 0.78553790 |
| 68 | MAP3K14 | 0.76163371 |
| 69 | MAP2K1 | 0.74607438 |
| 70 | PRKACG | 0.73130710 |
| 71 | CSK | 0.72360538 |
| 72 | BMPR1B | 0.71543916 |
| 73 | PRKAA1 | 0.69427161 |
| 74 | NEK9 | 0.68063548 |
| 75 | TAOK1 | 0.67165248 |
| 76 | CAMK2G | 0.67135909 |
| 77 | DYRK1B | 0.66456760 |
| 78 | JAK1 | 0.64010245 |
| 79 | FGFR3 | 0.63890640 |
| 80 | ICK | 0.61832017 |
| 81 | GSK3A | 0.61631890 |
| 82 | BLK | 0.61433233 |
| 83 | CDK6 | 0.61046953 |
| 84 | PDPK1 | 0.60945910 |
| 85 | FGFR2 | 0.60611482 |
| 86 | TAOK2 | 0.60326729 |
| 87 | MAP3K1 | 0.56426084 |
| 88 | CDC42BPA | 0.54700227 |
| 89 | SGK3 | 0.54056072 |
| 90 | BMX | 0.53858360 |
| 91 | KSR2 | 0.52518335 |
| 92 | PRKCQ | 0.50421952 |
| 93 | STK38L | 0.49568842 |
| 94 | GRK1 | 0.49557423 |
| 95 | MAPK15 | 0.47750416 |
| 96 | PDGFRA | 0.46326590 |
| 97 | MELK | 0.44864198 |
| 98 | GRK5 | 0.44843901 |
| 99 | STK24 | 0.44688464 |
| 100 | MYLK | 0.43388053 |
| 101 | EPHA4 | 0.42809583 |
| 102 | MAPK12 | 0.42697726 |
| 103 | FER | 0.41245787 |
| 104 | TIE1 | 0.39274218 |
| 105 | PAK4 | 0.38300462 |
| 106 | IKBKE | 0.37538763 |
| 107 | PRKCA | 0.37513355 |
| 108 | CAMK2D | 0.37060399 |
| 109 | EPHA3 | 0.36874499 |
| 110 | PRPF4B | 0.36226571 |
| 111 | MAP3K5 | 0.36073880 |
| 112 | PINK1 | 0.35053494 |
| 113 | MAP3K8 | 0.34934261 |
| 114 | MAP3K6 | 0.34767524 |
| 115 | PDK1 | 0.34140752 |
| 116 | CAMK2B | 0.34104402 |
| 117 | TYRO3 | 0.33087846 |
| 118 | TESK2 | 0.32090283 |
| 119 | SRC | 0.31893544 |
| 120 | PAK3 | 0.31520051 |
| 121 | HIPK2 | 0.29856826 |
| 122 | MAP4K1 | 0.29284661 |
| 123 | TGFBR2 | 0.29254933 |
| 124 | CAMK1D | 0.28851191 |
| 125 | IGF1R | 0.27289520 |
| 126 | WNK4 | 0.26547802 |
| 127 | PRKG1 | 0.26512732 |
| 128 | NLK | 0.25945986 |
| 129 | UHMK1 | 0.25658504 |
| 130 | STK10 | 0.25134976 |
| 131 | MAPK7 | 0.24606424 |
| 132 | CDK4 | 0.23628154 |
| 133 | RET | 0.23348646 |
| 134 | PIM1 | 0.22326803 |
| 135 | FYN | 0.20572126 |
| 136 | WNK3 | 0.19391820 |
| 137 | PRKCD | 0.19245889 |
| 138 | CDK9 | 0.18359199 |
| 139 | DAPK3 | 0.18176915 |
| 140 | STK11 | 0.18090032 |
| 141 | MAP3K13 | 0.16781380 |
| 142 | YES1 | 0.16272434 |
| 143 | PRKACA | 0.14571672 |
| 144 | FGR | 0.11473240 |
| 145 | CSF1R | 0.10704379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78148609 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44659915 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.36390843 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02357186 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89877715 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59213995 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45752185 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.45361657 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42718149 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38435297 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28554726 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25460587 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21296137 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16914586 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14660418 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.07585612 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.01814885 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95156513 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94379788 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89830707 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88885634 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.86494749 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.86355997 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.81046502 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76909009 |
| 26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.72471679 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70842239 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.70639245 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69665251 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67598435 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.67440633 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60930813 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60118861 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59298237 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57460581 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.51451620 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48983187 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.44278300 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41272813 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40692710 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.40482811 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37312413 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34393585 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25800797 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23174915 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.21240926 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19835586 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19578748 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.18740494 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16374752 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16109389 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15692875 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11139828 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10586234 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98611779 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96489895 |
| 57 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92591555 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90564259 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90079885 |
| 60 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87152822 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86414202 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.85254217 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.73030736 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.72694357 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68878217 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68812968 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.68763254 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68208218 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.65517343 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53083784 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49147719 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47574661 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47296397 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45889269 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45252110 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41773319 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41605729 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.34705945 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33942967 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.32095219 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30780689 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27500561 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26231316 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.23243571 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.22686253 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.20736339 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.19338004 |
| 88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18267698 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17731058 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15455528 |
| 91 | Pertussis_Homo sapiens_hsa05133 | 0.15403217 |
| 92 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.14782999 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14266016 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10892209 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.10055668 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.07274085 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06333756 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05480302 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.05417977 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.03886866 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.00844006 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00557991 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2253241 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2154480 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2038124 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | -0.2003820 |
| 107 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1466247 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1432505 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1400942 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1380157 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1376514 |
| 112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1206910 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1039755 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0950709 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0614861 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0302278 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0247820 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0173117 |
| 119 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.0135871 |
| 120 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | -0.0077609 |

